Leydig cell agenesis: genes and variants
Explore variant evidence for Leydig cell agenesis across 1 analyzed protein (LHCGR). Linked ClinVar records include 10 pathogenic or likely pathogenic variants, 6 variants of uncertain significance and 7 with conflicting classifications.
Coverage includes proteins already analyzed in CATVariant, not every gene involved in this condition. Database links are associations, not an assessment of clinical gene–disease validity. Computable evidence prioritizes variants for expert review and does not reclassify them. Counts refer to the selected disease label.
Data updated 2026-10-21. Automated aggregation, not a clinical review date.
Download variant evidence (CSV)
Genes linked to Leydig cell agenesis
LHCGR: Lutropin-choriogonadotropic hormone receptor
It responds to luteinizing hormone and chorionic gonadotropin to stimulate gonadal steroidogenesis, ovulation, and male sexual differentiation. Activating variants can cause male-limited precocious puberty, whereas loss-of-function variants cause Leydig-cell hypoplasia or infertility.
10 ClinVar pathogenic / likely pathogenic and 13 uncertain variants in LHCGR have source records linked to Leydig cell agenesis. Association strength is not clinical gene validity.
ClinVar pathogenic and likely pathogenic variants linked to Leydig cell agenesis
| Variant | Position | Protein part | Clinical label |
|---|---|---|---|
| LHCGR D578G | 578 | Transmembrane | Pathogenic / likely pathogenic (★★) |
| LHCGR S616Y | 616 | Transmembrane | Pathogenic / likely pathogenic (★★) |
| LHCGR E354K | 354 | Extracellular | Pathogenic / likely pathogenic (★) |
| LHCGR A498V | 498 | Transmembrane | Pathogenic / likely pathogenic (★) |
| LHCGR D578N | 578 | Transmembrane | Pathogenic / likely pathogenic (★) |
| LHCGR C343S | 343 | Extracellular | Pathogenic / likely pathogenic |
| LHCGR V144F | 144 | LRR 2 | Pathogenic / likely pathogenic |
| LHCGR C543R | 543 | Transmembrane | Pathogenic / likely pathogenic |
| LHCGR A593P | 593 | Transmembrane | Pathogenic / likely pathogenic |
| LHCGR L502P | 502 | Transmembrane | Pathogenic / likely pathogenic |
Which prediction tools work for Leydig cell agenesis
Observed separation of ClinVar pathogenic / likely pathogenic from benign / likely benign variants (AUROC × 100). This benchmark is not a clinical recommendation.
- CATVariant: 98 out of 100 (learned from overlapping clinical labels, so this is optimistic)
- ESM1b (LLR): 96 out of 100
- PolyPhen-2: 95 out of 100 (learned from overlapping clinical labels, so this is optimistic)
- AlphaMissense: 94 out of 100
- SIFT: 92 out of 100
Same protein, different disease
- Gonadotropin-independent familial sexual precocity also has ClinVar records linked to LHCGR variants; they fall mostly in different places as the Leydig cell agenesis variants (12 pathogenic / likely pathogenic).
Diseases related to Leydig cell agenesis
- Gonadotropin-independent familial sexual precocity, also linked to LHCGR
- Pseudohermaphroditism, also linked to LHCGR
- Leydig cell hypoplasia, also linked to LHCGR
Frequently asked questions
Which genes have records linked to Leydig cell agenesis?
This view contains 1 analyzed proteins: LHCGR. Links come from clinical records and association databases. They do not imply that every listed gene is a validated cause, and missing genes may not yet be analyzed.
What do the clinical classifications mean?
Linked records include 10 pathogenic or likely pathogenic variants, 6 variants of uncertain significance and 7 with conflicting classifications. Labels summarize source records; multi-condition records may not make a separate assertion for this disease. Check the original record and review status.
Does the evidence score change a VUS classification?
No. 0 VUS or conflicting variants reach the likely-pathogenic points range on the computable criteria available here. This is a research prioritization signal, not a clinical classification. Patient, family and other required evidence may be missing.
Can I download the variant evidence?
Download the CSV for all 26 variants in the selected disease scope, including clinical labels, review status, evidence criteria, predictor scores, functional measurements and population frequency where available.
About this data
Variant–disease links come from ClinVar, Open Targets and UniProt, pooled from eligible public CATVariant analyses of each human protein. Evidence scores use the ACMG/AMP Bayesian points scale with computable criteria only (position among known disease variants, rarity in gnomAD, calibrated predictors, deep mutational scanning); there is no family or patient data, so they prioritise variants for expert review and never classify them.
Download every variant as CSV · Browse all diseases · Methods · About the Center